We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu
IMPORTANT: Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Muscle Strength and Inflammatory Response in Patients With Inclusion Body Myositis (IBMan)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00898989
Recruitment Status : Completed
First Posted : May 12, 2009
Last Update Posted : December 21, 2010
Sponsor:
Collaborator:
Information provided by:

Study Description
Brief Summary:
Comparison of a group of 20 IBM patients with 20 controls matched on age, gender and weight.

Condition or disease
Inclusion Body Myositis

Study Design

Study Type : Observational
Estimated Enrollment : 42 participants
Observational Model: Case Control
Time Perspective: Prospective
Official Title: Evaluation of Muscle Strength and Inflammatory Response in Patients With Inclusion Body Myositis
Study Start Date : April 2009
Primary Completion Date : April 2010
Study Completion Date : April 2010


Groups and Cohorts

Group/Cohort
Inclusion Body Myositis
Control


Outcome Measures

Primary Outcome Measures :
  1. muscle strength [ Time Frame: 2 evaluations at an interval of 9 months ]

Secondary Outcome Measures :
  1. immune response [ Time Frame: 1 measure at inclusion ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Primary care clinic
Criteria

Inclusion Criteria:

  • Age > 18 years old
  • Written consent

Exclusion Criteria:

  • Current infection
  • Cancer within 1 year
  • Immune deficiency
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00898989


Locations
France
Hopital Pitié-Salpêtrière
Paris, France, 75013
Sponsors and Collaborators
Institut de Myologie, France
Assistance Publique - Hôpitaux de Paris
More Information

Responsible Party: Olivier BENVENISTE MD PHD, Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier: NCT00898989     History of Changes
Other Study ID Numbers: 2009-a00055-52
First Posted: May 12, 2009    Key Record Dates
Last Update Posted: December 21, 2010
Last Verified: December 2010

Additional relevant MeSH terms:
Myositis
Myositis, Inclusion Body
Muscular Diseases
Musculoskeletal Diseases
Neuromuscular Diseases
Nervous System Diseases